Pancreatic Cancer Research

ResearcherZhongda Hospital Southeast UniversityActive in the last 2 years

Zeqian Yu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5101130193. Sources: OpenAlex.

Their work

Papers
13
Trials
0
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2011: 2 papers · 2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 2 papers · 2026: 1 paper

Papers 13

  1. The lactate-GPR81-AMIGO2 axis promotes pancreatic ductal adenocarcinoma progression and predicts poor prognosis. Co-author DOI 10.1016/j.cellsig.2026.112624↗
  2. TGFBI promotes EMT and perineural invasion of pancreatic cancer via PI3K/AKT pathway. Co-author DOI 10.1007/s12032-025-02736-y↗
  3. MMA-induced LOXL2+ PSCs promote linear ECM alignment in the aging pancreas leading to pancreatic cancer progression. Co-author DOI 10.1038/s41419-025-07751-5↗
  4. mTORC2 promotes pancreatic cancer progression and parp inhibitor resistance. Co-author DOI 10.32604/or.2023.029309↗
  5. Hsa_circ_0074298 promotes pancreatic cancer progression and resistance to gemcitabine by sponging miR-519 to target SMOC. Co-author DOI 10.7150/jca.62927↗
  6. Role of long intergenic non-protein coding RNA 00152 in pancreatic cancer glycolysis via the manipulation of the microRNA-185-5p/Krüppel-like factor 7 axis. Co-author DOI 10.7150/jca.63128↗
  7. miRNA-339-5p Plays an Important Role in Invasion and Migration of Pancreatic Cancer Cells. Co-author DOI 10.12659/msm.917038↗
  8. Pancreatic cancer-derived exosomes promote tumor metastasis and liver pre-metastatic niche formation. Co-author DOI 10.18632/oncotarget.18831↗
  9. Diabetes mellitus stimulates pancreatic cancer growth and epithelial-mesenchymal transition-mediated metastasis via a p38 MAPK pathway. Co-author DOI 10.18632/oncotarget.9533↗
  10. Folate-chitosan-gemcitabine core-shell nanoparticles targeted to pancreatic cancer. Co-author DOI 10.3978/j.issn.1000-9604.2013.09.04↗
  11. Lentivirus-based DsRed-2-transfected pancreatic cancer cells for deep in vivo imaging of metastatic disease. Co-author DOI 10.1007/978-1-61779-797-2_5↗
  12. Marker expression in circulating cancer cells of pancreatic cancer patients. Co-author DOI 10.1016/j.jss.2010.05.007↗
  13. Resveratrol induces apoptosis in pancreatic cancer cells. Co-author PMID 21740780↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jiahua Zhou · 7 shared papers, 2017–2026 · strength 1.38
  2. Jiahua Zhou · 6 shared papers, 2011–2023 · strength 0.45
  3. Qiannan Zhang · 1 shared paper, 2026 · strength 0.33
  4. Siyuan Tan · 1 shared paper, 2025 · strength 0.28
  5. Wenyuan Shi · 1 shared paper, 2025 · strength 0.28
  6. Tonglei Xu · 1 shared paper, 2025 · strength 0.27
  7. Zheng Zhang · 1 shared paper, 2025 · strength 0.27
  8. Haodong Tang · 1 shared paper, 2025 · strength 0.27
  9. Chiwen Bu · 1 shared paper, 2023 · strength 0.24
  10. Robert M. Hoffman · 3 shared papers, 2011–2017 · strength 0.16
  11. Yang Yang · 1 shared paper, 2022 · strength 0.16
  12. Chen Hong · 1 shared paper, 2022 · strength 0.16
  13. Haifeng Li · 1 shared paper, 2021 · strength 0.13
  14. De-Tong Yang · 3 shared papers, 2011–2013 · strength 0.10
  15. Fangfang Hu · 1 shared paper, 2016 · strength 0.06
  16. Yang Yang · 1 shared paper, 2016 · strength 0.06
  17. Lishan Wang · 1 shared paper, 2016 · strength 0.06
  18. Yong-Hui Wang · 1 shared paper, 2016 · strength 0.06
  19. Michael Bouvet · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.